Clinical trial Recruiting at 1 site Interventional Ages 60 to 85

Intermittent hypoxia to improve brain blood flow in older adults with type 2 diabetes

Official title: Intermittent Hypoxia Training and Cerebrovascular Health in Older Adults With Type 2 Diabetes

Run by University of Iowa · NCT07173543 · Data updated 2026-11-12

This trial will test whether brief, repeated bouts of lower oxygen (intermittent hypoxia) can improve brain blood flow and cognition in adults aged 60–85 with type 2 diabetes, compared with non-diabetic older adults and a sham (normoxia) control.

More Aging trials

Quick facts

Study typeInterventional
Ages60 Years to 85 Years
SexAll
Enrollment80 (estimated)
SponsorUniversity of Iowa
Academic / other
Locations1 site (Iowa City, Iowa)
StatusRecruiting
StartedSeptember 22, 2025
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedMarch 13, 2026
Trial IDNCT07173543 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60–85 with documented type 2 diabetes for at least one year, HbA1c between 6.5% and 10.0%, BMI ≤40 kg/m2, MoCA score ≥26, and without recent cardiovascular events, uncontrolled hypertension, obstructive sleep apnea, significant pulmonary or renal disease, dementia, or recent smoking are ideal candidates.

Probably not a fit

People with recent heart attack or stroke, symptomatic coronary disease or heart failure, uncontrolled blood pressure, obstructive sleep apnea, advanced lung or kidney disease, dementia, very poor glycemic control, or recent smokers are unlikely to benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, placebo-controlled interventional study comparing two intermittent hypoxia protocols to a sham normoxia condition in older adults with and without type 2 diabetes. Approximately 30 participants with documented T2D and 30 non-diabetic control subjects, all aged 60–85 and cognitively intact (MoCA ≥26), will undergo supervised intermittent hypoxia sessions and serial measurements of cerebrovascular function and cognitive performance. Key exclusion criteria include recent cardiovascular events, symptomatic coronary disease or heart failure, uncontrolled hypertension, obstructive sleep apnea, significant pulmonary or renal disease, active smoking, and dementia. Safety monitoring and standardized physiological assessments will be used to track tolerability and changes in cerebral perfusion and cognitive endpoints.

Why it matters

Potential benefit: If successful, this could provide a non-drug approach to improve cerebral blood flow and potentially slow cognitive decline in older adults with type 2 diabetes.

How similar studies have gone: Animal studies and small human pilot studies provide preliminary evidence that intermittent hypoxia can improve vascular function, but large randomized evidence in older adults with type 2 diabetes is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
For 30 patients with documented Type 2 diabetes

Inclusion Criteria:

* Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures.
* Age is \> or = 60 and \< or = 85 years of age
* Documented Type 2 diabetes
* Scoring 26 or higher on the MoCA test

Exclusion criteria:

* diagnosis of type 2 diabetes \< 1 year prior to enrollment
* HbA1c \<6.5% or \>10.0%
* body mass index \> 40 kg/m 2
* incident cardiovascular events in the last year (heart attack, stroke)
* symptomatic coronary artery disease and/or heart failure
* uncontrolled hypertension
* obstructive sleep apnea
* pulmonary disease
* dementia
* renal impairment with creatinine clearance (eGFR) of \<60 ml/min
* smoking or history of smoking within past one year

  30 nondiabetic control subjects will also be studied.

Inclusion criteria:

* Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures.
* Age is \> or = 60 and \< or = 85 years of age
* Scoring 26 or higher on the MoCA test

Exclusion criteria:

* Diagnosis of diabetes (Type 1 or Type 2)
* body mass index \> 40 kg/m2
* incident cardiovascular events in the last year (heart attack, stroke)
* symptomatic coronary artery disease and/or heart failure
* uncontrolled hypertension
* obstructive sleep apnea
* pulmonary disease
* dementia
* renal impairment with creatinine clearance (eGFR) of \<60 ml/min
* smoking or history of smoking within past one year

Where it's running

  • University of Iowa
    Iowa City, Iowa, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.